Abstract
Timing and dosing of chemical venous thromboembolism (VTE) prophylaxis in brain injury is controversial. Risk of bleeding while using high dose unfractionated heparin (UFH) in overweight patients to prevent VTE is also unknown. The purpose of this study was to describe the use of subcutaneous heparin 7500 units for VTE prophylaxis in overweight patients. This was a retrospective study comparing patients over 100 kg who received either 7500 units Q8 h (n = 141) (high dose group, HDG), or 5000 units Q8 h (n = 257) (traditional dose group, TDG), of UFH subcutaneously. Both groups had similar rates of bleeding complications. The incidence of drop in hemoglobin by two points in any 24 h was 14 % (20/141) HDG versus 11 % (28/257) TDG; P = 0.33. Hemoglobin drop by two points from baseline was 57 % (81/141) HDG versus 51 % (132/257) TDG; P = 0.24. The need for pRBC transfusion was 26 % (36/141) HDG versus 20 % (52/257) TDG; P = 0.22. An increase in aPTT from baseline by two times was 4 % (5/141) HDG versus 4 % (9/257) TDG, P = 0.59. Discontinuation of heparin therapy for association with progressive bleeding was not documented in any patients. No differences in minor bleeding complications were observed. There was no difference in the incidence of VTE: 5.7 % (8/141) HDG versus 9.3 % (24/257) TDG; P = 0.2. In univariate and multivariable logistic regression analysis, only the time of the initiation of heparin after admission was associated with the occurrence of VTE (median, IQR) 46 h (17–86) HDG versus 105 h (56–167) TDG; OR 1.2 (1.1–1.3); P < 0.001. High dose subcutaneous UFH was not associated with an increased risk of bleeding, nor did it decrease the incidence of VTE in overweight patients.
Similar content being viewed by others
References
Frim DM, Barker FG, Poletti CE, Hamilton AJ (1992) Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients. Neurosurgery 30:830–2; discussion 832–3
Hamilton MG, Hull RD, Pineo GF (1994) Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery 34:280–96; discussion 296
Goldhaber SZ, Dunn K, Gerhard-Herman M et al (2002) Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 122:1933–1937
Skaf E, Stein PD, Beemath A et al (2005) Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol 96:1731–1733. doi:10.1016/j.amjcard.2005.07.097
Kappelle LJ (2011) Preventing deep vein thrombosis after stroke: strategies and recommendations. Curr Treat Options Neurol 13:629–635. doi:10.1007/s11940-011-0147-4
Phelan HA (2012) Pharmacologic venous thromboembolism prophylaxis after traumatic brain injury: a critical literature review. J Neurotrauma 29:1821–1828. doi:10.1089/neu.2012.2459
Kiphuth IC, Staykov D, Köhrmann M et al (2009) Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage. A safety analysis. Cerebrovasc Dis 27:146–150. doi:10.1159/000177923
Wu T-C, Kasam M, Harun N et al (2011) Pharmacological deep vein thrombosis prophylaxis does not lead to hematoma expansion in intracerebral hemorrhage with intraventricular extension. Stroke 42:705–709. doi:10.1161/STROKEAHA.110.600593
Raabe A, Gerlach R, Zimmermann M, Seifert V (2001) Clinical articles the risk of haemorrhage associated with early postoperative heparin administration after intracranial surgery. Acta Neurochir 143:1–7
Dickinson LD, Miller LD, Patel CP, Gupta SK (1998) Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 43:1074–1081
Lacut K, Bressollette L, Le Gal G et al (2005) Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 65:865–869. doi:10.1212/01.wnl.0000176073.80532.a2
Boeer A, Voth E, Henze T, Prange HW (1991) Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 54:466–467
Dickmann U, Voth E, Schicha H et al (1988) Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage. Klin Wochenschr 66:1182–1183
Morgenstern LB, Hemphill JC, Anderson C et al (2010) Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 41:2108–2129. doi:10.1161/STR.0b013e3181ec611b
Connolly ES, Rabinstein AA, Carhuapoma JR et al (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 43:1711–1737. doi:10.1161/STR.0b013e3182587839
Lansberg MG, O’Donnell MJ, Khatri P, et al. (2012) Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e601S–36S. doi: 10.1378/chest.11-2302
Jauch EC, Saver JL, Adams HP et al (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947. doi:10.1161/STR.0b013e318284056a
Kim KS, Brophy GM (2009) Symptomatic venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage. Neurocrit Care 11:28–33. doi:10.1007/s12028-009-9201-4
Ageno W, Becattini C, Brighton T et al (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117:93–102. doi:10.1161/CIRCULATIONAHA.107.709204
Stein PD, Beemath A, Olson RE (2005) Obesity as a risk factor in venous thromboembolism. Am J Med 118:978–980. doi:10.1016/j.amjmed.2005.03.012
Goldhaber SZ, Grodstein F, Stampfer MJ et al (1997) A prospective study of risk factors for pulmonary embolism in women. JAMA 277:642–645
Goldhaber SZ, Savage DD, Garrison RJ et al (1983) Risk factors for pulmonary embolism. The Framingham Study. Am J Med 74:1023–1028
Katie S. Buehler PB, Abigail M. Yancey PB (2013) Underdosing in obesity—an epidemic: focus on anticoagulation
Patel JP, Roberts LN, Arya R (2011) Anticoagulating obese patients in the modern era. Br J Haematol 155:137–149. doi:10.1111/j.1365-2141.2011.08826.x
Shepherd MF, Rosborough TK, Schwartz ML (2003) Heparin thromboprophylaxis in gastric bypass surgery. Obes Surg 13:249–253. doi:10.1381/096089203764467153
Shepherd MF, Rosborough TK, Schwartz ML (2004) Unfractionated heparin infusion for thromboprophylaxis in highest risk gastric bypass surgery. Obes Surg 14:601–605. doi:10.1381/096089204323093354
Quebbemann B, Akhondzadeh M, Dallal R (2005) Continuous intravenous heparin infusion prevents peri-operative thromboembolic events in bariatric surgery patients. Obes Surg 15:1221–1224. doi:10.1381/096089205774512528
Conflict of interest
Sophie Samuel, Emitseilu K Iluonakhamhe, Eileen Adair, Natalie Macdonald, Kiwon Lee, Teresa Allison, Huimahn. A Choi declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Samuel, S., Iluonakhamhe, E.K., Adair, E. et al. High dose subcutaneous unfractionated heparin for prevention of venous thromboembolism in overweight neurocritical care patients. J Thromb Thrombolysis 40, 302–307 (2015). https://doi.org/10.1007/s11239-015-1202-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-015-1202-x